1. Carrying the torch & facing new challenges

   • Haidong Dong

   Editorial 03 November 2020 Pages: 2411 - 2412

2. Pretreatment body mass index and clinical outcomes in cancer patients following immune checkpoint inhibitors: a systematic review and meta-analysis

   • Haizhu Chen
   • Daquan Wang
   • Yuankai Shi

   Review 04 August 2020 Pages: 2413 - 2424

   

3. Current trends in cancer immunotherapy: a literature-mining analysis

   • Stamatia Pouliliou
   • Christos Nikolaidis
   • George Drosatos

   Original Article 15 June 2020 Pages: 2425 - 2439

   

4. Factors associated with ocular adverse event after immune checkpoint inhibitor treatment

   • Yong Joon Kim
   • Jihei Sara Lee
   • Christopher Seungkyu Lee

   Original Article 17 June 2020 Pages: 2441 - 2452

   

5. Functional effects of immune complexes formed between pembrolizumab and patient-generated anti-drug antibodies

   • Barry D. Hock
   • Judith L. McKenzie
   • Margaret J. Currie

   Original Article 16 June 2020 Pages: 2453 - 2464

   

6. Anti-tumor efficacy of plasmid encoding emm55 in a murine melanoma model

   • Brittany L. Bunch
   • Krithika N. Kodumudi
   • Joseph Markowitz

   Original Article 18 June 2020 Pages: 2465 - 2476

   

7. The role of myeloid-derived suppressor cells in increasing cancer stem-like cells and promoting PD-L1 expression in epithelial ovarian cancer

   • Naoko Komura
   • Seiji Mabuchi
   • Tadashi Kimura

   Original Article 19 June 2020 Pages: 2477 - 2499

   

8. The adjuvant effect of melanin is superior to incomplete Freund’s adjuvant in subunit/peptide vaccines in mice

   • Stefania Cuzzubbo
   • Claire Banissi
   • Antoine F. Carpentier

   Original Article 19 June 2020 Pages: 2501 - 2512

   

9. Variation in neutrophil to lymphocyte ratio (NLR) as predictor of outcomes in metastatic renal cell carcinoma (mRCC) and non-small cell lung cancer (mNSCLC) patients treated with nivolumab

   • A. Simonaggio
   • R. Elaidi
   • Y. A. Vano

   Original Article 19 June 2020 Pages: 2513 - 2522

   

10. Anlotinib optimizes anti-tumor innate immunity to potentiate the therapeutic effect of PD-1 blockade in lung cancer

    • Yinli Yang
    • Ling Li
    • Zhanyu Pan

    Original Article 23 June 2020 Pages: 2523 - 2532

    

11. Prognostic impacts of tumoral expression and serum levels of PD-L1 and CTLA-4 in colorectal cancer patients

    • Yusuke Omura
    • Yuji Toiyama
    • Masato Kusunoki

    Original Article 23 June 2020 Pages: 2533 - 2546

    

12. Increased IL-10+CD206+CD14+M2-like macrophages in alveolar lavage fluid of patients with small cell lung cancer

    • Xintong Hu
    • Yue Gu
    • Yanfang Jiang

    Original Article 24 June 2020 Pages: 2547 - 2560

    

13. A single-valent long-acting human CD47 antagonist enhances antibody directed phagocytic activities

    • Fenglan Wu
    • Yangsheng Qiu
    • Yuhong Xu

    Original Article 24 June 2020 Pages: 2561 - 2569

    

14. TIM-3 blockade combined with bispecific antibody MT110 enhances the anti-tumor effect of γδ T cells

    • Qingming Guo
    • Peng Zhao
    • Lin Hou

    Original Article 25 June 2020 Pages: 2571 - 2587

    

15. A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastases

    • Yanina Jansen
    • Vibeke Kruse
    • Bart Neyns

    Original Article 26 June 2020 Pages: 2589 - 2598

    

16. Dynamics of peripheral T cell clones during PD-1 blockade in non-small cell lung cancer

    • Fan Zhang
    • Hua Bai
    • Xueda Hu

    Original Article 26 June 2020 Pages: 2599 - 2611

    

17. Multi-antigen DNA vaccine delivered by polyethylenimine and Salmonella enterica in neuroblastoma mouse model

    • Maria V. Stegantseva
    • Veronika A. Shinkevich
    • Alexander N. Meleshko

    Original Article 27 June 2020 Pages: 2613 - 2622

    

18. Histopathological growth patterns correlate with the immunoscore in colorectal cancer liver metastasis patients after hepatectomy

    • Jie-ying Liang
    • Shao-yan Xi
    • Yu-hong Li

    Original Article 29 June 2020 Pages: 2623 - 2634

    

19. Characterizing caspase-1 involvement during esophageal disease progression

    • Gillian Barber
    • Akanksha Anand
    • Emma M. Creagh

    Original Article 01 July 2020 Pages: 2635 - 2649

    

20. Induction of systemic immune responses and reversion of immunosuppression in the tumor microenvironment by a therapeutic vaccine for cervical cancer

    • Yuxin Che
    • Yang Yang
    • Xuelian Wang

    Original Article 01 July 2020 Pages: 2651 - 2664

    

21. Increased Th17 activation and gut microbiota diversity are associated with pembrolizumab-triggered tuberculosis

    • Yun-Bin Zhang
    • Shi-Jia Liu
    • Fan Xia

    Research Report 06 August 2020 Pages: 2665 - 2671